ss ss ss ss ss ss ss ss ss
Material
TestBank:
s
Advanced PharmacologyforPrescribers 1stEdition Luu KayingoLatestEdi
ss s j s j j s
ss tion,2024
s
, Stuvia.com - The Marketplace to Buy and Sell your Study
ss ss ss ss ss ss ss ss ss
Material
Table ofContents j
Chapterj 1: An Introductionj to Evidence-Based Clinicalj PracticeGuidelines.................................................. 3
ss ss ss ss ss ss ss s
Chapterj2:Pharmacokinetics /Chapter3:Pharmacodynamics ........................................................................ 13
s ss s
Chapter4: Pharmacogeneticsj and Pharmacogenomics................................................................................. 25
ss ss ss
Chapter5:Pharmacology AcrossthejLife Span............................................................................................... 30
s s ss s s
Chapter 6: Drug-Therapy Prescribingjin Special Populations ........................................................................ 36
ss ss ss ss ss
Chapter7:DrugDevelopmentj and Approval.................................................................................................. 45
s s s ss ss
Chapter 8-Chapter 10: Foundations of Prescription WritingjChapter 9: ResponsibleControlled-
ss ss ss ss s s s s ss ss
s Substance Prescribing Chapter 10:Antibiotic Stewardship....................................................................... 51
s ss ss ss ss
Chapter11:Applied Calculationsjfor Prescribing .......................................................................................... 58
s s ss ss
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
ss ss ss ss ss s s ss ss ss
Focused PrescribingjChapter 13: Pharmacotherapyfor Ear, Nose,Mouth,andThroat Conditions/Chapter 14:
ss ss ss ss ss s s ss ss
Pharmacotherapyfor EyejConditions ........................................................................................................... 67
ss s
Chapter 15: Pharmacotherapy for Skin Conditions ........................................................................................ 74
ss ss ss ss ss
Chapter 16: Pharmacotherapy for Neurologic Conditions ............................................................................. 81
ss ss ss ss ss
Chapterj 17:Pharmacotherapyfor Cardiovascular Conditions ...................................................................... 94
ss s ss ss
Chapterj 18: Pharmacotherapyforj Respiratory Conditions ......................................................................... 106
ss s ss ss
Chapter 19: PharmacotherapyforGastrointestinal Conditionsand Conditions RequiringNutritional Support
ss ss ss ss ss ss
................................................................................................................................................................... 117
Chapterj 20:PharmacotherapyforjGenitourinary Conditions ....................................................................... 128
ss s s ss
Chapter21:Pharmacotherapyfor Renal, Acid–Base, Fluid,and ElectrolytejDisorders.................................. 133
s s ss s ss s ss
Chapter 22:Pharmacotherapyfor Musculoskeletaland Rheumatologic Conditions ..................................... 146
ss s ss s ss ss
Chapter23:Therapeutic Applicationsjof Immunology and Vaccines............................................................ 158
s s ss ss ss ss
Chapter 24:Pharmacotherapyfor Endocrine Disorders ................................................................................ 163
ss s s ss s
Chapterj25:Pharmacotherapyfor Hematologic Disorders............................................................................ 174
s s s ss
Chapterj26:Hematology/Oncologyand Supportive Careforj the Nononcologist ......................................... 190
s ss ss ss ss
Chapter 27:Pharmacotherapy Relatedj to Women’s Health Conditions....................................................... 196
ss s ss ss ss ss ss
Chapter 28:Pharmacotherapy Related to Men’s Health Conditions ............................................................. 211
ss s ss ss ss ss ss
Chapter 29:Pharmacotherapy Relatedj to Transgender Care ....................................................................... 217
ss s ss ss ss ss
Chapter 30:AntimicrobialPharmacotherapy ............................................................................................... 224
s s s
Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................... 235
ss s s
Chapter32:PsychopharmacologyandIntegrative Health:Combined TreatmentofPsychiatricjandNeurocogn
s s s ss s ss s s
itiveConditions.......................................................................................................................................... 247
ss s
Chapter 33:Pharmacotherapyfor Pain Management................................................................................... 257
ss s ss ss
Chapterj34: Substance Use Disorderj III: Health Promotion and Maintenance .............................................. 267
s ss ss ss ss ss ss ss
Chapterj35:Over-the-CounterjMedications................................................................................................. 283
Chapterj36: Pharmacotherapy forjObesity................................................................................................... 291
ss ss
, Stuvia.com - The Marketplace to Buy and Sell your Study
ss ss ss ss ss ss ss ss ss
Material
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
ss ss ss s s ss ss ss ss
MULTIPLECHOICE s
• What is the primary purpose of the nursing assessment?
ss ss ss ss ss ss ss ss
A. Identifyingj underlyingj pathologic ss ss s s conditions
B. Assisting thej physician in identifying medical conditions ss ss s s ss ss ss
C. Determining the patients mental status ss s s ss ss
D. Exploring patientj responses to health problems ss ss s s s s s s
ANS:jD
A nursingassessment is done to identify thejpatients response to health proble
ss ss ss ss ss ss ss ss ss ss
ms. Duringthe nursingjassessment phase, a comprehensiveinformation
ss ss ss ss ss ss
base i s developed through ajphysical examination, nursingjhistory,
s s ss ss ss ss ss ss ss
medication
ss histo ry, and professionaljobservation. ss ss ss s s
Identifyingunderlyingpathologic condition
s s s and assistingjthe physician s s s s ss ss ss
in identifyingmedical conditions is notjpart of thej nursingjprocess.
ss ss ss ss ss ss ss s s
Determiningjthe patients mental status is one partj of the nurs ing
ss ss s s ss s s s s ss ss ss ss ss
assessment, but it is notjthe primary purpose.
ss ss s s s s s s ss ss
DIF: Cognitive Level: Comprehension
ss ss ss
REF:dm 36 OBJ:1 |3 TOP:NursingjPro
ss s ss ss s ss s ss s
cess Step: Assessment
ss ss s
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
ss ss ss ss ss ss ss ss
• Whatjis the basis of the NANDAI taxonomy? ss ss ss ss ss ss
A. Functional health patterns s s ss
B. Human response patterns ss s s
C. Basic human needs ss ss
D. Pathophysiologic needs s s
ANS:jB
The NANDA I taxonomy identifiesj human response patterns. Functional
ss ss ss ss ss ss ss ss
components of health patterns are limited to activity, fluidvolume, nutrition,
ss ss ss ss ss ss ss ss ss ss
self care, and sensory perception. Basic human needs comprise less than mer
ss ss ss ss ss ss ss ss ss ss ss ss
ely health patterns. Pathophysiologic needs are
ss ss ss notpart of the scopejof ss ss ss s s ss ss ss
NAN DAI.
ss ss
, Stuvia.com - The Marketplace to Buy and Sell your Study
ss ss ss ss ss ss ss ss ss
Material
DIF: Cognitive Level: Knowledge REF:
ss ss ss ss
pp. 37-38 OBJ: 5 TOP:
ss ss ss ss
NursingjProcess Step: Diagnosis ss ss
MSC: NCLEX Client Needs Category: Physiological Integrity
ss ss ss ss ss ss
• Which task is included in the assessment step of the nursing process?
ss ss ss ss ss ss ss ss ss ss ss
A. Establishing patient goals/outcomes ss s s
B. Implementingj the nursingj care plan (NCP) ss s s ss s s s s
C. Measuringj goal/outcome achievement ss s s
D. Collectingjand communicatingj data s s ss
ANS: D s
Data are collected and communicated in the assessment phase of the
ss ss ss ss ss ss ss ss ss ss
nursingp rocess. Establishingjgoals is thejfunction of planning.
ss ss ss ss ss ss ss
Implementingthe NCP is the function of implementation. ss ss ss ss ss s s
Measuringjoutcom e achievement is the function of evaluation.
ss s s ss ss ss ss ss ss
DIF: Cognitive Level: Comprehension
ss ss ss
REF:dm 36 OBJ:2 |3 TOP:NursingPro
ss s ss ss s ss s ss s s
cess Step: Assessment
ss ss s
MSC: NCLEXj Clientj Needs Category: Health Promotion and Maintenance
ss ss ss ss ss ss ss s s
• Which statement regardingj nursing diagnoses is accurate?
ss ss ss ss s s s s
a. Nursingdiagnoses remain the same for as longjas the disease is present. ss ss ss s s ss ss ss ss s s s s
b. Nursing diagnoses are written to identify disease states. ss ss ss ss ss ss ss
c. Nursing diagnoses describe patient problems that nurses treat. ss s s s s ss s s ss s s
d. Nursing diagnoses identify causes related to illness. ss ss ss ss s s s s
ANS:jC
Diagnostic statements identify problemsja nurse is independently able to treat
ss ss ss ss ss ss ss ss ss
within the scope of professional practice. Nursingjdiagnoses vary with the ch
ss ss ss ss ss ss ss ss ss ss ss
angingjcondition of the patient. The responsepatterns arejunique to the
ss ss s s ss ss ss ss ss ss
patien
ss t and are notjdisease specific. Nursingdiagnoses describethe
s s ss ss ss ss ss ss
patients humanjr esponse pattern.
ss ss ss s
DIF: Cognitive Level: Comprehension
ss ss ss